The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare.
The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare. They Six Protected Classes at stake include therapies for epilepsy, mental illness, cancer, HIV, and organ transplants.
The ads will be featured in The Washington Post, The New york Times, The Hill, Roll Call, and Politico. Read the full press release.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen